This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Florida Research Foundation Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Guimei Tian: Innovator in Cancer Treatment
Introduction
Guimei Tian is a notable inventor based in Hawthorne, FL (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.
Latest Patents
Guimei Tian holds a patent for a polypeptide inhibitor of de novo lipogenesis in cancer cells. The patent describes a method for treating cancer in a subject by administering a therapeutically effective amount of a composition that includes a polypeptide. This polypeptide comprises an amino acid sequence corresponding to the C-terminal SUMO-interacting motif (SIM2) of a DAXX protein. Importantly, the disclosed polypeptide is not a functional DAXX protein but competes with endogenous DAXX for binding to SUMO.
Career Highlights
Guimei Tian is associated with the University of Florida Research Foundation Inc., where he continues to advance his research in cancer therapies. His work is pivotal in exploring new avenues for cancer treatment, showcasing his dedication to improving patient outcomes.
Collaborations
Guimei collaborates with esteemed colleagues, including Daiqing Liao and Iqbal Mahmud, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the field of cancer treatment.
Conclusion
Guimei Tian's innovative approach to cancer treatment through his patented methods exemplifies the importance of research and collaboration in advancing medical science. His contributions are vital in the ongoing fight against cancer, and his work continues to inspire future innovations in the field.